Olympus Corporation (FRA:OLY)

Market Cap	12.20B +6.0%
Revenue (ttm)	5.62B +7.8%
Net Income	421.55M -30.3%
EPS	0.38 -28.0%
Shares Out	n/a
PE Ratio	28.93
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	10.90
Previous Close	11.10
Day's Range	10.90 - 10.90
52-Week Range	6.80 - 11.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Olympus

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology product...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1919
• Employees: 28,138
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OLY

Financial Performance

In fiscal year 2026, Olympus's revenue was 1.01 trillion, an increase of 1.34% compared to the previous year's 997.33 billion. Earnings were 68.17 billion, a decrease of -42.16%.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error